Johnson & Johnson’s $55bn bet: What it means for healthcare and investors
Johnson & Johnson is investing $55 billion in U.S. manufacturing, R&D, and technology, reinforcing its leadership in pharmaceuticals. Find out more. Read More
How Yuwell Medical is transforming player safety in Chinese football
Yuwell Medical has signed an official partnership with CFA Team China in a collaboration that aims to elevate healthcare support within Chinese football. Announced at ... Read More
Smith+Nephew expands margins and cash flow—What it means for shareholders
Smith+Nephew, a global leader in medical technology, has reported a strong financial performance for 2024, highlighting steady revenue growth, increased profitability, and record-breaking cash flow. ... Read More
PAVmed secures $2.4m to advance Veris Health’s implantable cancer monitoring technology
PAVmed Inc., a diversified commercial-stage medical technology company, has completed a $2.37 million private placement financing, reinforcing its investment in Veris Health Inc., a majority-owned ... Read More
OSR Holdings completes merger, set to begin Nasdaq trading on February 18
OSR Holdings, Inc. has officially completed its business combination with OSR Holdings Co., Ltd., marking a pivotal milestone in its expansion within the global healthcare ... Read More
BD Q1 FY25 earnings: Strong growth, higher guidance, and biosciences separation strategy
Becton, Dickinson and Company, a global leader in medical technology, reported a 9.8% year-over-year revenue increase in its first-quarter fiscal 2025 earnings, reaching $5.2 billion. ... Read More
Zimmer Biomet expands foot and ankle portfolio with $1.2bn Paragon 28 acquisition
Zimmer Biomet Holdings, Inc. has entered into a definitive agreement to acquire Paragon 28, Inc., a leading medical device company specialising in foot and ankle ... Read More
Sensome’s Clotild clot-sensing guidewire shows promise in peripheral artery disease treatment studies
A breakthrough innovation in the treatment of peripheral artery disease (PAD) could soon transform clinical practice, offering clinicians a real-time solution to accurately identify clot ... Read More
Shocking: Olympus CEO Kaufmann resigns amid explosive drug allegations
In a major upheaval, Olympus Corporation’s President and CEO, Stefan Kaufmann, resigned amid allegations of illegal drug purchases, triggering a severe market reaction. Olympus confirmed ... Read More
Getinge to enter organ transplantation market with $477m acquisition of Paragonix Technologies
Getinge, a prominent Swedish medical technology company, has announced its acquisition of Paragonix Technologies, Inc., a U.S.-based leader in organ preservation and transportation products. The ... Read More